Published online Mar 31, 2009.
https://doi.org/10.5051/jkape.2009.39.1.77
Effect of rhBMP-2 produced by Escherichia coli expression system on bone formation in rat calvarial defects
Abstract
Purpose
Recombinant human bone morphogenetic protein-2(rhBMP-2) has been evaluated as potential candidates for periodontal and bone regenerative therapy. In spite of good prospects in BMP applications, there is economically unavailable for clinical use in dental area. The purpose of this study was to evaluate the osteogenic effect of rhBMP-2 produced by E.coli expression system.
Materials and methods
Eight-mm critical-size calvarial defects were created in 48 male Sprague-Dawley rats. The animals were divided into 6 groups of 8 animals each. Each group received one of the following: Negative control(sham-surgery control), positive control(absorbable collagen sponge(ACS) alone) and experimental(ACS loaded with rhBMP-2). Defects were evaluated by histologic and histometric parameters following 2- and 8-week healing intervals.
Results
The experimental group showed significant defect closure at 2 and 8weeks than the sham surgery and positive control groups. Moreover, the experimental group showed significantly greater new bone and augmented area than the other groups at both 2 and 8weeks.
Conclusion
rhBMP-2 produced by E.coli expression system may be effective for bone regeneration.
Figure 1
Schematic diagram of the calvarial osteotomy defect showing the histometric analysis
Figure 2
Representative photomicrographs of defect site receiving the sham surgery at 2weeks(arrow heads : defect margin ; HE stain, magnification × 10).
Figure 3
Representative photomicrographs of defect site receiving the sham surgery at 8weeks(arrow heads : defect margin ; HE stain, magnification × 10).
Figure 4
Representative photomicrographs of defect site receiving the positive control at 2weeks(arrow heads : defect margin ; HE stain, magnification × 10).
Figure 5
Representative photomicrographs of defect site receiving the positive control at 8weeks(arrow heads : defect margin ; HE stain, magnification × 10).
Figure 6
Representative photomicrographs of defect site receiving the experimental at 2weeks(arrow heads:defect margin ; HE stain, magnification × 10).
Figure 7
Representative photomicrographs of defect site receiving the experimental at 2weeks(arrow heads:defect margin, PB:pre-existing bone, NB:new bone ; HE stain, magnification × 100).
Figure 8
Representative photomicrographs of defect site receiving the experimental at 2weeks(central portion ; HE stain, magnification × 100)
Figure 9
Representative photomicrographs of defect site receiving the experimental at 8weeks(arrow heads: defect margin ; HE stain, magnification × 10).
Figure 10
Representative photomicrographs of defect site receiving the experimental at 8weeks(arrow heads:defect margin, PB:pre-existing bone, NB:new bone ; HE stain, magnification × 100).
Figure 11
Representative photomicrographs of defect site receiving the experimental at 8weeks(central portin; HE stain, magnification × 100).
Table 1
Study design
Table 2
Defect closure(group means±SD; n=8, %)
Table 3
New bone area(group means±SD; n=8, mm2)
Table 4
Augmented area(group means±SD; n=8, mm2)
References
-
Sampath TK, Maliakal JC, Hauschka PV, et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 1992;267:20352–20362.
-
-
Urist MR, Lietze A, Dawson E. Beta-tricalcium phosphate delivery system for bone morphogenetic protein. Clin Orthop Relat Res 1984:277–280.
-
-
Urist MR, Nilsson O, Rasmussen J, et al. Bone regeneration under the influence of a bone morphogenetic protein(BMP) beta tricalcium phosphate(TCP) composite in skull trephine defects in dogs. Clin Orthop Relat Res 1987:295–304.
-
-
Choi KH, Moon KO, Kim SH, et al. Purification and biological activity of recombinant human bone morphogenetic protein-2 produced by E.coli expression system. J Korean Acad Periodontol 2008;38:41–50.
-
-
Lynch SE, Marx RE, Nevins M, Wisner-Lynch LA. In: Tissue Engineering - Application in oral and maxillofacial surgery and periodontics. 2nd Edition. Chicago: Quintessence Publishing Co, Inc; 2008. pp. 163-165.
-
-
Martin GJ Jr, Boden SD, Marone MA, et al. Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate : Important lessons learned regarding dose, carrier, and safety. J Spinal Disord 1999;12:179–186.
-
-
Yang X, Fang J, Luo Y. Effects of recombinant human bone morphogenetic protein 2 and osteogenic agents on proliferation and differentiation of rat mesenchymal stem cells. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2007;21:140–144.
-